Izumi T, Saeki Y, Akanuma Y, Takaku F, Kasuga M
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
J Biol Chem. 1988 Jul 25;263(21):10386-93.
We have prepared site-specific antibodies toward human insulin, insulin-like growth factor-I, and epidermal growth factor receptors with chemically synthesized peptides derived from the cDNA-predicted amino acid sequences of these receptors. Two classes of antibodies were produced toward each receptor: one toward the carboxyl termini and the other against the kinase domains containing sequences homologous to the tyrosyl phosphorylation site of the product of src gene (pp60v-src). Both classes of antibodies specifically immunoprecipitated the appropriate 125I-ligand-receptor complexes and [35S]methionine-labeled receptors with almost equal potencies. Antibodies toward the kinase domains inhibited both autophosphorylation and tyrosine kinase activity of the corresponding receptors in a cell-free system, whereas antibodies toward the carboxyl termini did not. Microinjection of the kinase-inhibitory antibodies into the cytoplasm of human epidermoid carcinoma KB cells blocked the ability of the corresponding ligand to induce membrane ruffling. In contrast, these inhibitory antibodies did not block the ability of noncorresponding ligands to induce the same response. Furthermore, control immunoglobulin and antibodies toward the carboxyl termini did not block this biological response. These results support a role for the tyrosine-specific protein kinase activities of these growth factor receptors in mediating their biological effects and suggest that the regions homologous to the tyrosyl phosphorylation site of pp60v-src are important for these kinase activities both in cell-free and intact cell systems.
我们利用从这些受体的cDNA预测氨基酸序列衍生而来的化学合成肽,制备了针对人胰岛素、胰岛素样生长因子-I和表皮生长因子受体的位点特异性抗体。针对每种受体产生了两类抗体:一类针对羧基末端,另一类针对含有与src基因产物(pp60v-src)的酪氨酸磷酸化位点同源序列的激酶结构域。这两类抗体都能以几乎相同的效力特异性免疫沉淀相应的125I-配体-受体复合物和[35S]甲硫氨酸标记的受体。针对激酶结构域的抗体在无细胞系统中抑制相应受体的自身磷酸化和酪氨酸激酶活性,而针对羧基末端的抗体则没有这种作用。将激酶抑制性抗体显微注射到人表皮样癌KB细胞的细胞质中,可阻断相应配体诱导膜皱襞的能力。相反,这些抑制性抗体不会阻断非相应配体诱导相同反应的能力。此外,对照免疫球蛋白和针对羧基末端的抗体不会阻断这种生物学反应。这些结果支持了这些生长因子受体的酪氨酸特异性蛋白激酶活性在介导其生物学效应中的作用,并表明与pp60v-src的酪氨酸磷酸化位点同源的区域在无细胞和完整细胞系统中对这些激酶活性都很重要。